Gilead Sciences (GILD +4.2%) trades higher into the close after J.P. Morgan added the drug maker...

|About: Gilead Sciences, Inc. (GILD)|By:, SA News Editor

Gilead Sciences (GILD +4.2%) trades higher into the close after J.P. Morgan added the drug maker to its "focus list" earlier today, citing growth in its research pipeline and the undervalued potential of the company's new HIV drugs. Separately, Deutsche calls the company "its top value stock," with a potential 40% return over the next year.